Skip to NavigationSkip to content

cancer research

E. coli strain in the gut may increase risk of bowel cancer, new study finds

A type of E. coli infection may increase a person’s chance of developing bowel cancer, according to a new study published in Nature.

This type of E. Coli, present in the gut, is found in one out of five people and releases a toxin which experts say can damage the cells that line the bowel. This can potentially turn some cells cancerous over a period of time.

Virus DNA found in cancer cells

The first comprehensive survey of viruses found with different types of cancer has been conducted by researchers.

Researchers from the University of East Anglia discovered traces of viruses in 13% of the samples studied and also further identified some of the mechanisms that viruses use to trigger carcinogenic mutations. These findings come after University of East Anglia scientists pioneered a new way of finding the bacteria and viruses associated with cancer.

Landmark study set to transform cancer treatment

Over a thousand scientists have built the most detailed picture of cancer ever in a landmark study.

Their research was published in the journal Nature, and was carried out by the Pan-Cancer Analysis of Whole Genomes Consortium. They analyzed the genetic code of 2,658 cancers.

The study said that cancer was like a 100,000-piece jigsaw and until this study 99% of the pieces were missing. It has taken teams in 37 countries more than a decade to figure out.

NICE rejects Keytruda for routine use in NHS bladder cancer treatment

The National Institute for Health and Care Excellence (NICE) has given an initial ‘no’ for Keytruda’s (pembrolizumab) use in treating bladder cancer through the NHS.

The immunotherapy is currently available as a treatment option on the NHS through the Cancer Drugs Fund, and will continue to be until at least January 2020 when NICE will review its initial decision.

Smoking may limit immune system's ability to fight cancer, study shows

Smoking may limit the body’s ability to fight melanoma, according to a study published in the journal Cancer Research.

The study of more than 700 melanoma patients in the north of England provides evidence to suggest that smoking may blight the immune system’s response against melanoma which may in turn reduce survival.

New $2 million programme aims at increasing diversity in cancer research

The National Cancer Institute are developing a joint cancer drug discovery and development, and research education programme focused towards the development of treatments for cancers that have an increased risk of incidence and mortality  among underserved communities in the United States, including Latinos, African-Americans and Native Americans.

2017 National Cancer Research Institute (NCRI) Cancer Conference

Blood test able to detect cancer a year in advance

A team at the Francis Crick Institute, based in London, has discovered a new way of analysing blood in patients who had previously suffered from cancer to determine whether there was a possibility of recurrence. The test, known as a liquid biopsy, is able to detect traces of unstable cancer DNA in the blood, which give clues to cancer development in patients.

New immunotherapy-based cancer research limits cancer spread by 75%

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the body, identifying one that reduced the spread of tumours by 75%. The study was conducted in mice that had been genetically engineered to be missing certain specified genes and were then injected with melanomas to examine the difference in cancer spread.

New research reveals how cancer cells grow and spread through body

Research conducted by The Institute of Cancer Research (ICR), co-funded by Cancer Research UK, has discovered how cancer cells are able to spread through the human body, despite the physical restraints that usually stop this occurring. Cancer cells that are able to spread the body were found to be activating a molecule called YAP, which allows them to move around cell tissue.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches